Dr Rae Sedgwick, PHD | |
311 Allcutt Ave, # 377, Bonner Springs, KS 66012-1501 | |
(913) 441-3800 | |
(913) 441-3450 |
Full Name | Dr Rae Sedgwick |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 311 Allcutt Ave, Bonner Springs, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306824818 | NPI | - | NPPES |
06086011 | Other | KS | BLUE CROSS BLUE SHIELD ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 352 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rae Sedgwick, PHD Po Box 377, 311 Allcutt Ave, Bonner Springs, KS 66012-0377 Ph: (913) 441-3800 | Dr Rae Sedgwick, PHD 311 Allcutt Ave, # 377, Bonner Springs, KS 66012-1501 Ph: (913) 441-3800 |
News Archive
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
Influenza is associated with as many as 7,300 deaths annually in nursing home residents, but the vaccination rate for nursing home staff is only 54 percent, according to a study in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.
The key genetic events responsible for initiating the early stages of a type of childhood leukemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the ‘founder' genetic mutation for this type of leukemia, present in all the cancer cells, could be used in the development of new targeted drugs.
The Myelodysplastic Syndromes (MDS) Foundation says a study published this week in the Journal of Clinical Oncology concludes VIDAZA (azacitidine) "prolongs survival and is well tolerated" in patients with acute myeloid leukemia (AML) - an aggressive form of leukemia that in many cases progresses from MDS.
› Verified 9 days ago